APA (7th ed.) Citation

Moitra, P., Chatterjee, A., Kota, P. K., Epari, S., Patil, V., Dasgupta, A., . . . Gupta, T. (2022). Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: A single-institutional pharmacogenetic study. Journal of neuro-oncology, 156(3), 625-634. https://doi.org/10.1007/s11060-022-03944-6

Chicago Style (17th ed.) Citation

Moitra, Prithwijit, Abhishek Chatterjee, Priti Khatri Kota, Sridhar Epari, Vijay Patil, Archya Dasgupta, Pradnya Kowtal, Rajiv Sarin, and Tejpal Gupta. "Temozolomide-induced Myelotoxicity and Single Nucleotide Polymorphisms in the MGMT Gene in Patients with Adult Diffuse Glioma: A Single-institutional Pharmacogenetic Study." Journal of Neuro-oncology 156, no. 3 (2022): 625-634. https://doi.org/10.1007/s11060-022-03944-6.

MLA (9th ed.) Citation

Moitra, Prithwijit, et al. "Temozolomide-induced Myelotoxicity and Single Nucleotide Polymorphisms in the MGMT Gene in Patients with Adult Diffuse Glioma: A Single-institutional Pharmacogenetic Study." Journal of Neuro-oncology, vol. 156, no. 3, 2022, pp. 625-634, https://doi.org/10.1007/s11060-022-03944-6.